JP Morgan Initiates Coverage On CareTrust REIT with Neutral Rating, Announces Price Target of $41
JP Morgan analyst Michael Mueller initiates coverage on CareTrust REIT (NYSE:CTRE) with a Neutral rating and announces Price Target of $41.
Stocks · News reference
8-K filing — CareTrust REIT, Inc. (CTRE)
Filed: 2026-10-02 AccNo: 0001628280-26-064352 Size: 4 MB Item 2.01: Completion of Acquisition or Disposition of Assets Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
UBS Maintains Buy on CareTrust REIT, Lowers Price Target to $44
UBS analyst Michael Goldsmith maintains CareTrust REIT (NYSE:CTRE) with a Buy and lowers the price target from $48 to $44.
CareTrust REIT (CTRE) Upgraded to Buy: What Does It Mean for the Stock?
CareTrust REIT has been upgraded to Zacks Rank #2 (Buy) based on upward trends in earnings estimates. The upgrade reflects improving business fundamentals and positions the stock in the top 20% of Zacks-covered stocks, suggesting potential for near-term price appreciation driven by institutional investor buying pressure.
Raymond James Maintains Outperform on CareTrust REIT, Lowers Price Target to $42
Raymond James analyst David Rodgers maintains CareTrust REIT (NYSE:CTRE) with a Outperform and lowers the price target from $45 to $42.